SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001099910-23-000188
Filing Date
2023-10-27
Accepted
2023-10-27 15:57:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d.htm SC 13D 118697
  Complete submission text file 0001099910-23-000188.txt   120034
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Subject) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88731 | Film No.: 231355423
SIC: 2834 Pharmaceutical Preparations

Mailing Address 31 BILTON ST TEANECK NJ 07666
Business Address
Lee Elvin Sanghwan (Filed by) CIK: 0001996260 (see all company filings)

Type: SC 13D